Anantco Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 50.00 K
- Company Age 2 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
About Anantco Pharmachem
Anantco Pharmachem Private Limited (APPL) is a Private Limited Indian Non-Government Company incorporated in India on 20 July 2022 (Two years and six months 21 days old ). Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 50.00 K , as per Ministry of Corporate Affairs (MCA) records.
Anant Thakore and Neha Thakore serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U52609MH2022PTC387153
-
Company No.
387153
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
20 Jul 2022
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Anantco Pharmachem?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Neha Thakore
|
Director | 20-Jul-2022 | Current |
|
Anant Thakore
|
Director | 20-Jul-2022 | Current |
Financial Performance of Anantco Pharmachem.
Anantco Pharmachem Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Anantco Pharmachem?
Unlock access to Anantco Pharmachem's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Neema Sales LlpNeha Thakore is a mutual person
-
Anantco Enterprises Private LimitedAnant Thakore and Neha Thakore are mutual person
-
Avik Pharmaceutical LimitedAnant Thakore and Neha Thakore are mutual person
-
Neema Sales Private LimitedNeha Thakore is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Anantco Pharmachem?
Anantco Pharmachem has a workforce of 0 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Anantco Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anantco Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.